+13.1%
GSK vs MTCH
+27.4%
-14.3%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MTCH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +4.4% | +0.6% | +4.4% |
| 7D | +4.9% | -4.4% | +9.3% | +5.4% |
| 30D | +9.9% | -0.3% | +10.2% | +9.9% |
| 3M | +0.2% | -2.0% | +2.2% | +0.3% |
| 6M | +2.3% | +6.4% | -4.1% | +1.8% |
| YTD | +7.1% | +27.3% | -20.3% | +2.7% |
| 1Y | +13.1% | +30.3% | -17.2% | +8.2% |
| All | +13.1% | +27.4% | -14.3% | +8.2% |
Cumulative growth
Daily Returns
Daily percentage return beside MTCH.
Daily Out/Under-Performance
Portfolio return minus MTCH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MTCH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MTCH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling